AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 1 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $19,655,000 | -19.0% | 571,610 | -29.7% | 0.01% | -33.3% |
| Q3 2014 | $24,272,000 | +120.6% | 813,127 | +48.2% | 0.01% | +200.0% |
| Q2 2014 | $11,003,000 | -41.1% | 548,534 | -20.2% | 0.00% | -50.0% |
| Q1 2014 | $18,691,000 | +145.3% | 687,683 | +87.1% | 0.01% | +100.0% |
| Q4 2013 | $7,620,000 | -18.9% | 367,598 | -28.8% | 0.00% | 0.0% |
| Q3 2013 | $9,391,000 | +80.8% | 516,009 | +65.2% | 0.00% | +200.0% |
| Q2 2013 | $5,195,000 | -0.3% | 312,404 | +11.1% | 0.00% | -66.7% |
| Q4 2012 | $5,212,000 | -46.8% | 281,196 | -29.7% | 0.00% | -25.0% |
| Q3 2012 | $9,788,000 | -6.9% | 400,132 | +2.4% | 0.00% | -20.0% |
| Q2 2012 | $10,510,000 | +566.9% | 390,851 | +360.7% | 0.01% | +400.0% |
| Q1 2012 | $1,576,000 | – | 84,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,883,879 | $101,243,000 | 9.44% |
| Tamarack Capital Management, LLC | 1,250,000 | $25,913,000 | 6.14% |
| Healthcare Value Capital, LLC | 334,481 | $6,934,000 | 5.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,113,385 | $85,270,000 | 4.42% |
| KING INVESTMENT ADVISORS INC/TX | 312,890 | $6,486,000 | 2.96% |
| Broadfin Capital, LLC | 961,100 | $19,924,000 | 2.63% |
| SECTOR GAMMA AS | 462,504 | $9,588,000 | 2.59% |
| TAMRO Capital Partners LLC | 1,898,717 | $39,360,000 | 1.62% |
| Elk Creek Partners, LLC | 84,090 | $1,743,000 | 1.25% |
| Artal Group S.A. | 1,500,000 | $31,095,000 | 1.12% |